MORN vs VALU: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. MORN and VALU share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined MORN and VALU exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Morningstar is an investment-research and financial-data provider whose products span five reportable segments: the Morningstar Direct Platform (data, research, Direct, and Advisor Workstation), PitchBook (private-capital data, analytics, and AI-enabled software for venture capital, private equity, private credit, and M&A), Morningstar Credit (credit ratings, research, and analytics through DBRS Morningstar), Morningstar Wealth (investment products, advisor platforms, and managed portfolios), and Morningstar Retirement. The business is built on proprietary datasets, independent research, and widely used ratings and indexes that embed deeply into advisor, asset-manager, and institutional workflows, giving it high switching costs and durable, largely recurring revenue.

Full MORN guide

Value Line, Inc. is a New York based investment-research firm best known for The Value Line Investment Survey, a long-running publication that assigns proprietary ranks (for timeliness, safety, and more) to thousands of stocks. Its core business produces and sells investment periodicals and their underlying research, and it licenses its copyrights, trademarks, proprietary ranks, and data to third parties such as financial platforms and fund sponsors. This publishing business carries high gross margins (reported around 82%) but grows slowly, as print and legacy research compete with a flood of free and low-cost online alternatives.

Full VALU guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• MORN drivers: PitchBook and private-markets data; Morningstar Credit (DBRS) rebound.
• VALU drivers: EAM asset-management profits; Legacy research and data licensing.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: Credit-ratings revenue is cyclical and tracks debt-issuance volumes, so a slowdown in structured finance or corporate issuance can quickly pressure a fast-growing segment. For VALU, the clearest risk is that Value Line does not control EAM: it holds only non-voting interests, so it depends on a manager it cannot direct, and EAM's fee income falls if its assets under management shrink in a market downturn or through redemptions.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick MORN if you believe its drivers more; VALU if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the MORN and VALU guides.

MORN. Morningstar reported Q1 2026 revenue near $644.8 million, up about 11% year over year, with operating profit up more than 35% and diluted EPS around $2.73, up roughly 50%, both ahead of consensus. Growth was broad-based but led by Morningstar Credit (up about 38%) and PitchBook, and the company continued buying back stock. At a mid-to-high-teens trailing earnings multiple, the shares reflect steady growth plus continued margin recovery rather than a sharp re-acceleration.

VALU. Figures are approximate, drawn from Value Line's fiscal 2026 filings, and tied to the asOf date; verify live numbers before acting. Two structural quirks make VALU hard to value on a simple multiple: much of its economic value sits in a non-voting claim on EAM rather than in consolidated operating income, and reported profit swings with investment gains on its securities portfolio. Its thin float and insider control also mean the share price can move on liquidity as much as on fundamentals.

Headline figures (approximate, July 2026): MORN shows revenue (ttm) ~$2.5B, q1 2026 revenue ~$644.8M (up ~10.8% YoY), q1 2026 diluted eps ~$2.73 (up ~50% YoY), morningstar credit growth ~+38% YoY (Q1 2026); VALU shows revenue (annual) Approximately $34 million to $35 million from publishing and licensing, per recent reporting (EAM fee income is reported separately as a non-operating interest), net income (9 months ended jan 31, 2026) Approximately $18.1 million, or about $1.92 per share, up roughly 8% year over year, gross margin High, reported around 82% on the publishing business, eam contribution A large, market-sensitive share of profit; EAM receipts rose roughly 20% in Q1 FY2026 and about 16% in the fiscal first half.

MORN and VALU are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined MORN and VALU exposure against your real portfolio. It is not an investment adviser.